Titre : Récepteur de la mélanocortine de type 4

Récepteur de la mélanocortine de type 4 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Staphylococcus aureus
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Récepteur de la mélanocortine de type 4 : Questions médicales les plus fréquentes", "headline": "Récepteur de la mélanocortine de type 4 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Récepteur de la mélanocortine de type 4 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-11", "dateModified": "2025-04-05", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Récepteur de la mélanocortine de type 4" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Récepteurs à la mélanocortine", "url": "https://questionsmedicales.fr/mesh/D044101", "about": { "@type": "MedicalCondition", "name": "Récepteurs à la mélanocortine", "code": { "@type": "MedicalCode", "code": "D044101", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.750.660.285.500" } } }, "about": { "@type": "MedicalCondition", "name": "Récepteur de la mélanocortine de type 4", "alternateName": "Receptor, Melanocortin, Type 4", "code": { "@type": "MedicalCode", "code": "D044105", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ya-Xiong Tao", "url": "https://questionsmedicales.fr/author/Ya-Xiong%20Tao", "affiliation": { "@type": "Organization", "name": "Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA." } }, { "@type": "Person", "name": "Peter Kühnen", "url": "https://questionsmedicales.fr/author/Peter%20K%C3%BChnen", "affiliation": { "@type": "Organization", "name": "Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin und Humboldt-Universität zu Berlin, Institute for Experimental Pediatric Endocrinology, Augustenburger Platz 1, 13353 Berlin, Germany." } }, { "@type": "Person", "name": "Patrick Scheerer", "url": "https://questionsmedicales.fr/author/Patrick%20Scheerer", "affiliation": { "@type": "Organization", "name": "Group Protein X-ray Crystallography and Signal Transduction, Institute of Medical Physics and Biophysics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, D-10117 Berlin, Germany." } }, { "@type": "Person", "name": "Heike Biebermann", "url": "https://questionsmedicales.fr/author/Heike%20Biebermann", "affiliation": { "@type": "Organization", "name": "Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin und Humboldt-Universität zu Berlin, Institute for Experimental Pediatric Endocrinology, Augustenburger Platz 1, 13353 Berlin, Germany." } }, { "@type": "Person", "name": "Ren-Lei Ji", "url": "https://questionsmedicales.fr/author/Ren-Lei%20Ji", "affiliation": { "@type": "Organization", "name": "Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Staphylococcus aureus vaccine strategy: Promise and challenges.", "datePublished": "2023-03-13", "url": "https://questionsmedicales.fr/article/36958134", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.micres.2023.127362" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an", "datePublished": "2023-05-24", "url": "https://questionsmedicales.fr/article/37222591", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/aac.01317-22" } }, { "@type": "ScholarlyArticle", "name": "The Staphylococcus aureus-antagonizing human nasal commensal Staphylococcus lugdunensis depends on siderophore piracy.", "datePublished": "2024-10-22", "url": "https://questionsmedicales.fr/article/39438987", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40168-024-01913-x" } }, { "@type": "ScholarlyArticle", "name": "Dynamics of a Staphylococcus aureus infective endocarditis simulation model.", "datePublished": "2022-05-27", "url": "https://questionsmedicales.fr/article/35460117", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/apm.13231" } }, { "@type": "ScholarlyArticle", "name": "Antimicrobial Resistance Patterns of Outpatient Staphylococcus aureus Isolates.", "datePublished": "2024-06-03", "url": "https://questionsmedicales.fr/article/38874923", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2024.17199" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Récepteurs de surface cellulaire", "item": "https://questionsmedicales.fr/mesh/D011956" }, { "@type": "ListItem", "position": 6, "name": "Récepteurs peptidiques", "item": "https://questionsmedicales.fr/mesh/D018000" }, { "@type": "ListItem", "position": 7, "name": "Récepteur hormone hypophysaire", "item": "https://questionsmedicales.fr/mesh/D011979" }, { "@type": "ListItem", "position": 8, "name": "Récepteur corticotrophine", "item": "https://questionsmedicales.fr/mesh/D018043" }, { "@type": "ListItem", "position": 9, "name": "Récepteurs à la mélanocortine", "item": "https://questionsmedicales.fr/mesh/D044101" }, { "@type": "ListItem", "position": 10, "name": "Récepteur de la mélanocortine de type 4", "item": "https://questionsmedicales.fr/mesh/D044105" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Récepteur de la mélanocortine de type 4 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Récepteur de la mélanocortine de type 4", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Général", "headline": "Général sur Récepteur de la mélanocortine de type 4", "description": "Erreur lors de la génération.", "url": "https://questionsmedicales.fr/mesh/D044105?mesh_terms=Staphylococcus+aureus&page=2#section-général" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Erreur lors de la génération.", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Veuillez réessayer ultérieurement." } } ] } ] }

Sources (4198 au total)

The Staphylococcus aureus-antagonizing human nasal commensal Staphylococcus lugdunensis depends on siderophore piracy.

Bacterial pathogens such as Staphylococcus aureus colonize body surfaces of part of the human population, which represents a critical risk factor for skin disorders and invasive infections. However, s... We could cultivate S. lugdunensis from the noses of 6.3% of healthy human volunteers. In addition, S. lugdunensis DNA could be identified in metagenomes of many culture-negative nasal samples indicati...

Antimicrobial Resistance Patterns of Outpatient Staphylococcus aureus Isolates.

Oral non-β-lactam antibiotics are commonly used for empirical therapy of Staphylococcus aureus infections, especially in outpatient settings. However, little is known about potential geographic hetero... To characterize the spatiotemporal trends of resistance to non-β-lactam antibiotics among community-onset S aureus infections, including regional variation in resistance rates and geographical heterog... This cross-sectional study used data from Veterans Health Administration clinics collected from adult outpatients with S aureus infection in the conterminous 48 states and Washington, DC, from January... Resistance to lincosamides (clindamycin), tetracyclines, sulfonamides (trimethoprim-sulfamethoxazole [TMP-SMX]), and macrolides.... Spatiotemporal variation of S aureus resistance to these 4 classes of non-β-lactam antibiotics, stratified by methicillin-resistant S aureus (MRSA) and methicillin-sensitive S aureus (MSSA), and subdi... A total of 382 149 S aureus isolates from 268 214 unique outpatients (mean [SD] age, 63.4 [14.8] years; 252 910 males [94.29%]) were analyzed. There was a decrease in the proportion of MRSA nationwide... In this study of outpatient S aureus isolates, MRSA became less common over the 10-year period, and MRSA isolates were increasingly resistant to tetracyclines and TMP-SMX. Geographic analysis indicate...

Ethnic differences in staphylococcus aureus acquisition in cystic fibrosis.

Hispanic people with CF (pwCF) have increased morbidity than non-Hispanic White pwCF, including increased risk of Pseudomonas aeruginosa. We aimed to determine if Staphylococcus aureus (S. aureus) acq... This longitudinal cohort study of pwCF ages 0-25 years in the CF Foundation Patient Registry compared acquisition of methicillin-sensitive S. aureus (MSSA), methicillin-resistant S. aureus (MRSA), per... Of 10,640 pwCF, 7.5% were Hispanic and 92.5% were non-Hispanic White. Hispanic pwCF had a 19% higher risk of acquiring MSSA (HR 1.19, 95% CI 1.10-1.28, p<0.001) and 13% higher risk of acquiring MRSA (... Hispanic pwCF <25 years of age have an increased risk of acquiring MSSA and acquired MSSA and MRSA at an earlier age. Differences in S. aureus acquisition may contribute to increased morbidity in Hisp...

Optimal drug therapy for Staphylococcus aureus bacteraemia in adults.

Staphylococcus aureus is a significant human pathogen, causing a variety of infections, from skin and soft tissue infections to endocarditis, bone and joint infections and deep tissue abscesses. Morta... In recent years, optimized dosing of antibiotics is increasingly being recognized as a cornerstone of management for severe infections including S. aureus bacteraemia. This comprehensive review detail... This review details the different PK/PD targets for drugs used to treat S. aureus bacteraemia and how to apply them in various scenarios. The drug doses that achieve them, and the risks of toxicity ar...